Unveiling the Breakthrough: Beicell Therapeutics’ Human Chemical Reprogramming Kit Induces Primary Human CiPS Cells，Verified by Third-Party
On May 20, 2023, Beicell Therapeutics launched the "Human Chemical Reprogramming Induced Pluripotent Stem Cell Kit" for the first time at the Second Forum of Peking University Third Hospital. The kit is based on the latest breakthrough achievement of the team of Professor Deng Hongkui of Peking University "Using chemical small molecules to induce human adult cells to transform into pluripotent stem cells (Nature, 2022; Cell Stem Cell, 2023)"
Cell Stem Cell: Deng Hongkui’s team at Peking University establishes a more rapid and efficient human cell chemical reprogramming system
On March 20, 2023, Beijing time, Deng Hongkui's team at Peking University published a research paper entitled "Highly efficient and rapid generation of human pluripotent stem cells by chemical reprogramming" in the international academic journal Cell Stem Cell.
Deng Hongkui’s team from Peking University published a report in Nature on the research results of using small chemical molecules to induce human Somatic cells to transform into pluripotent stem cells
On April 13, 2022, Deng Hongkui's research team from the School of Life Sciences of Peking University and the Peking University Tsinghua Life United Center published a research paper entitled "Chemical reprogramming of human somatic cells to pluripotent stem cells" online in the international academic journal Nature.
